FDA OKs New Lung Cancer Drug

Friday, 12 Jul 2013 12:37 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink

 
The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation.
 
The drug, Gilotrif, was approved along with a companion diagnostic kit that can help determine if a patient's lung cancer cells express the epidermal growth factor receptor (EGFR) gene mutation.
 
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and represents about 85 percent of all lung cancers. EGFR gene mutations are present in about 10 percent of NSCLC.
 
Lung cancer is the leading cause of cancer-related death among men and women, and according to the National Cancer Institute, an estimated 228,190 Americans will be diagnosed with, and 159,480 will die from, the disease this year.
 
The companion diagnostic kit, called therascreen EGFR RGQ PCR Kit, is made by Qiagen N.V.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Researchers Take 'Baby Step' Toward Anti-Aging Drug

Thursday, 25 Dec 2014 11:23 AM

Researchers could be closing in on a fountain of youth drug that can delay the effects of aging and improve the health . . .

Simple Tricks to Avoid Holiday Weight Gain

Thursday, 25 Dec 2014 11:17 AM

Overeating is common during the holidays, but there are strategies that can help you eat in moderation, an expert says.  . . .

Complex Job Helps Maintain Brain Fitness

Thursday, 25 Dec 2014 11:11 AM

Regardless of IQ, people who work at complex jobs have a slightly higher chance of being better thinkers as they age, a  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved